Zhejiang Hisun Pharmaceutical Co., Ltd. Stock: price and insider trades · China
海正药业
No insider purchase over the last 90 days. The latest, by 喻舜兵, was filed 02 Aug 2022.
Zhejiang Hisun Pharmaceutical Co., Ltd.: what insiders have been doing
Zhejiang Hisun Pharmaceutical Co., Ltd. has a thin disclosure history in our data (latest filing: 2 August 2022). New filings will appear here as soon as they are published. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Since the insiders bought
- -1.1%Entry CN¥11.35 · Close at T+365 CN¥11.23
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Zhejiang Hisun Pharmaceutical Co., Ltd. Sell (bearish), based on 1 analysts. Average price target: CN¥9.20.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,000 shares100.0% of flowA股XSHGSSE:173000005747517860Canonical exit: 31 Oct 2022 (T+90)
1 of 1 declaration
About Zhejiang Hisun Pharmaceutical Co., Ltd.
海正药业 is a Chinese company in the pharmaceutical sector, focused on the research, development, and manufacturing of medications. It is listed on the Shanghai Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
